Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: inside (292)

How-to-access-the-VLE

Description: How to access the VLE How to access the VLE 1. Type into your web browser address bar www.uhs-vle.co.uk 2. Once l
Url: /Media/UHS-website-2019/Docs/Working-here/How-to-access-the-VLE.pdf

How to access the VLE

Description: How to access the VLE How to access the VLE 1. Type into your web browser address bar www.uhs-vle.co.uk 2. Once l
Url: /Media/UHS-website-2019/Docs/Working-here/How-to-access-the-VLE.docx

Peptide receptor radionuclide therapy (PRRT) - patient information

Description: This factsheet explains what peptide receptor radionuclide therapy (PRRT) is, what the therapy involves, and what the possible benefits and risks
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Peptide-receptor-radionuclide-therapy-PRRT-3016-PIL.pdf

Targeting-Shared-Mechanisms-Call-1

Description: Call for Applications: Targeting shared mechanisms in immune-mediated inflammatory diseases Introduction and rationale There are mo
Url: /Media/Southampton-Clinical-Research/Downloads/Targeting-Shared-Mechanisms-Call-1.pdf

Image guided biopsy for brain tumour - patient information

Description: Patient information factsheet Image-guided biopsy for a brain tumour We've given you this factsheet because you are due to have an
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Image-guided-biopsy-for-brain-tumour-2130-PIL.pdf

Testing for COVID-19 (maternity) - patient information

Description: We have given you this factsheet because we are offering you a test for COVID-19. We hope this factsheet will
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Testing-for-COVID-19-maternity.pdf

VR-RituximabVenetoclaxCycle_1_VenetoclaxDoseTitration

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) Cycle 1 – Venetoclax dose titration Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclaxCycle-1-VenetoclaxDoseTitration.pdf

Chlorambucil_7_Rituximab

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Chlorambucil (7 day)-Rituximab Regimen • CLL – Chlorambucil (7 day)-Rituximab Indica
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-7-Rituximab.pdf

Chlorambucil_14_Rituximab

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Chlorambucil (14 day)-Rituximab Regimen • CLL – Chlorambucil (14 day)-Rituximab Indi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-14-Rituximab.pdf

Niraparib

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCERS Regimen NIRAPARIB • Ovarian Cancer – Niraparib Indication • Niraparib is recommended as mai
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Niraparib.pdf

611 to 620 of 1000

Previous … 60 61 62 63 64 … Next